HNH
NewsIntelligence ExchangeReportsSubscribe FreeDonate
Back
  1. Home
  2. /
  3. News
  4. /
  5. Capital
  6. /
  7. Altis Labs Raises US$25 Million Series A Co-Led by OrbiMed and Qiming Venture Partners USA to Accelerate Clinical Development
Capital

Altis Labs Raises US$25 Million Series A Co-Led by OrbiMed and Qiming Venture Partners USA to Accelerate Clinical Development

Business Wire·September 17, 2026
Altis Labs Raises US$25 Million Series A Co-Led by OrbiMed and Qiming Venture Partners USA to Accelerate Clinical Development

Altis Labs has secured $25 million in Series A funding to advance its computational imaging platform, which integrates clinical data to improve patient outcomes. While the company focuses on clinical development, the investment highlights the ongoing influx of venture capital into health-tech solutions that leverage data to personalize patient care and treatment pathways.

HNH Insight

This article represents the broader venture capital landscape in health-tech as of September 17, 2026, reflecting the high level of investor interest in data-driven health platforms that align with the technological infrastructure needs of the 'Food is Medicine' movement.

Read original article on Business Wire
Venture Capital
Health-Tech
Funding
Clinical Development

Exchange Discussion

Join the expert conversation on this article in the HN&H Intelligence Exchange. Professional discussion only — cite your sources.

and subscribe to comment.

No comments yet.

Want to go deeper? Start a dedicated discussion thread in the Exchange.

More in Capital

Capital

Invest in Food for Health®

Food for Health·Oct 3, 2026
Capital

AI Is Reshaping Clinical Nutrition: Precision Therapy, Venture Capital, and the Food-as-Medicine Frontier

HNH Food is Medicine Intelligence·Oct 2, 2026
Capital

Venture Capital & Startup Funding — October 1, 2026

OriginBrief·Oct 2, 2026
See all Capital articles
HNH

The definitive source for Food is Medicine intelligence. No paywall. No credit card. Free weekly intelligence covering Food is Medicine, Produce Prescriptions, Medically Tailored Meals, Medicaid, Policy, and Innovation.

Navigate

  • News Feed
  • Intelligence Exchange
  • Reports
  • Partnerships
  • Sponsorship
  • Subscribe Free
  • Donate

Topics

  • Food is Medicine
  • Medically Tailored Meals
  • Produce Prescriptions
  • 1115 Waivers
  • Capital
  • Legislation

Legal

  • Terms of Use
  • Privacy Policy
  • Community Guidelines
  • Editorial Standards
  • Do Not Sell or Share My Personal Information
  • Contact Us

Sourcing & Editorial Policy

HNH Intelligence summarizes original reporting, press releases, and announcements from across the Food is Medicine industry. Every summary is written independently and credited to its original author and outlet, with a direct link to the full story at the source. HNH's added value is the cross-industry analysis and context layered on top, connecting individual developments to the broader trends shaping the field.

This platform provides educational and policy discussion only and does not provide medical advice.

© 2026 Hunger, Nutrition & Health. All rights reserved.

The Authoritative Voice of Food is Medicine.

We use cookies

We use cookies to enhance your experience, analyze traffic, and personalize content. You can choose how we use your data.

Free Industry Intelligence

Get the Weekly Report in Your Inbox — Free

Join thousands of Food is Medicine leaders receiving curated news, expert analysis, and policy updates every week.

  • Daily curated news across 6 industry pillars
  • Weekly executive summary & HNH analysis
  • Policy impact & capital movement tracking
Subscribe for Free Read This Week’s Report· Sep 28

No paywall. No spam. Unsubscribe anytime.